Reinsurance Group of America (RGA)
(Delayed Data from NYSE)
$212.64 USD
+0.90 (0.43%)
Updated Jul 12, 2024 04:00 PM ET
After-Market: $212.64 0.00 (0.00%) 7:58 PM ET
2-Buy of 5 2
A Value A Growth A Momentum A VGM
Reinsurance Group (RGA) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Upside to Average Price Target |
---|---|---|---|
$222.42 | $253.00 | $166.00 | 4.60% |
Price Target
Based on short-term price targets offered by 12 analysts, the average price target for Reinsurance Group comes to $222.42. The forecasts range from a low of $166.00 to a high of $253.00. The average price target represents an increase of 4.6% from the last closing price of $212.64.
Analyst Price Targets (12)
Broker Rating
Reinsurance Group currently has an average brokerage recommendation (ABR) of 1.50 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by 12 brokerage firms. The current ABR compares to an ABR of 1.50 a month ago based on 12 recommendations.
Of the 12 recommendations deriving the current ABR, eight are Strong Buy and two are Buy. Strong Buy and Buy respectively account for 66.67% and 16.67% of all recommendations. A month ago, Strong Buy made up 66.67%, while Buy represented 16.67%.
Broker Rating Breakdown
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 8 | 8 | 8 | 8 | 8 |
Buy | 2 | 2 | 2 | 2 | 2 |
Hold | 2 | 2 | 2 | 2 | 2 |
Sell | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 |
ABR | 1.50 | 1.50 | 1.50 | 1.50 | 1.50 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
6/26/2024 | Evercore Partners | Thomas Gallagher | Strong Buy | Strong Buy |
6/14/2024 | Raymond James | Wilma Burdis | Strong Buy | Strong Buy |
5/5/2024 | Not Identified | Not Identified | Strong Buy | Strong Buy |
4/12/2024 | Not Identified | Not Identified | Moderate Buy | Moderate Buy |
4/11/2024 | Wells Fargo Securities | Elyse Greenspan | Strong Buy | Strong Buy |
4/10/2024 | UBS | Brian R Meredith | Strong Buy | Strong Buy |
4/5/2024 | Piper Sandler | John Barnidge | Strong Buy | Strong Buy |
3/26/2024 | Keefe Bruyette & Woods | Ryan Krueger | Not Available | Moderate Buy |
1/30/2024 | Not Identified | Not Identified | Strong Buy | Strong Buy |
12/15/2023 | Goldman Sachs | Alex Scott | Strong Buy | Strong Buy |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 1.50 |
ABR (Last week) | 1.50 |
# of Recs in ABR | 12 |
Average Target Price | $222.42 |
LT Growth Rate | NA |
Industry | Insurance - Life Insurance |
Industry Rank by ABR | 89 of 252 |
Current Quarter EPS Est: | 4.94 |